{
    "clinical_study": {
        "@rank": "144748", 
        "arm_group": [
            {
                "arm_group_label": "Arm A", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Arm B", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The study was performed to assess the effect of PH-797804 on neutrophils (white cells) in\n      the sputum after a challenge with an endotoxin (inhaled LPS). Neutrophils are a sign of\n      inflammation and PH-797804 is being developed as a potential anti-inflammatory treatment for\n      patients with Chronic Obstructive Pulmonary Disease (COPD)."
        }, 
        "brief_title": "PH-797804 LPS Study in Healthy Volunteers", 
        "completion_date": {
            "#text": "March 2008", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy male or female (WONCBP), non atopic volunteers aged 18-50 years\n\n          -  Able to produce sputum\n\n        Exclusion Criteria:\n\n          -  Current Smokers\n\n          -  Abnormal liver function test\n\n          -  Respiratory Tract Infection within 4 weeks"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02084485", 
            "org_study_id": "A6631010"
        }, 
        "intervention": [
            {
                "arm_group_label": "Arm A", 
                "description": "30 MG Single dose", 
                "intervention_name": "PH-797804", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Arm B", 
                "description": "matching placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "COPD", 
            "LPS"
        ], 
        "lastchanged_date": "March 13, 2014", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A6631010&StudyName=PH-797804%20LPS%20study%20in%20Healthy%20Volunteers"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Denmark Hill", 
                    "country": "United Kingdom", 
                    "state": "London", 
                    "zip": "SE5 9PJ"
                }, 
                "name": "Pfizer Investigational Site"
            }
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Double-blind, Placebo-controlled, 2-way Crossover Study to Determine the Effects of a Single Oral Dose of Ph-797804 on Induced Sputum Inflammatory Markers Following Inhaled Lipopolysaccharide (Lps) Challenge in Healthy Volunteers", 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "March 2008", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Neutrophil & Macrophage count (total and differential)", 
                "measure": "Sputum Cell Counts", 
                "safety_issue": "No", 
                "time_frame": "6 hours post LPS challenge"
            }, 
            {
                "description": "TNF-\u03b1, MIP-1\u03b2, IL-6, MPO, MCP-1, GRO-\u03b1", 
                "measure": "Sputum Cytokines", 
                "time_frame": "6 hours post LPS challenge"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02084485"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Neutrophil count, GRO-\u03b1, TNF-\u03b1, MIP-1\u03b2, IL-6, MPO, MCP-1, CRP", 
            "measure": "Systemic Inflammatory Indices", 
            "safety_issue": "No", 
            "time_frame": "1, 4, 6 and 7 hours post LPS"
        }, 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2006", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}